The challenge of assuring continued post-trial access to beneficial treatment.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Yale Journal of Health Policy, Law, and Ethics

• Publication date

  Unknown publication date

• Fields of study

  Law, Medicine, Psychology

• Identifiers
  PMID 15742586
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ending Concerns about Undue Inducement

  2004cited by this paper
• Freebies for subject 641: a discussion of the ethical prospect of providing drug trial subjects with post-trial access to the drug tested--a Canadian perspective.

  1998cited by this paper

• Sharing Clinically Relevant Research Results with Active-Duty Special Operations Forces: Toward an Ethical Framework for Responsible Disclosure

  2026cites this paper
• Perspectives of stakeholders on post-trial access arrangements in Ethiopia: a qualitative study

  2025cites this paper
• What Happens After a Neural Implant Study? Neuroethics Expert Workshop on Post-Trial Obligations

  2024cites this paper
• When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research

  2023cites this paper
• Dimensions of Researcher Vulnerability in Qualitative Health Research and Recommendations for Future Practice

  2023cites this paper
• Acceso a medicamentos para enfermedades raras en el posestudio: una revisión integradora

  2022cites this paper
• Post-trial access to drugs for rare diseases: an integrative review

  2022influential citation
• Acesso a medicamentos para doenças raras no pós-estudo: revisão integrativa

  2022cites this paper
• Motives and risk perceptions of participants in a phase 1 trial for Hepatitis C Virus investigational therapy in pregnancy

  2021cites this paper
• Ethical considerations for HIV remission clinical research involving participants diagnosed during acute HIV infection

  2021cites this paper
• Formulating an Ethics of Pharmaceutical Disinvestment

  2020cites this paper
• Regulating international clinical research: an ethical framework for policy-makers

  2020cites this paper
• The Principles of Biomedical Scientific Writing: Materials and Methods

  2019cites this paper
• Posttrial Access to Medical Interventions: Intricacies, Challenges, and Solutions

  2019cites this paper
• Broadening the Debate About Post-trial Access to Medical Interventions: A Qualitative Study of Participant Experiences at the End of a Trial Investigating a Medical Device to Support Type 1 Diabetes Self-Management

  2019influential citation
• Globalization of Clinical Research and Assessment of Global Access to Treatments Approved between 2006-2015

  2019influential citation
• Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective

  2018cites this paper
• PARTICIPANTES DE ENSAIOS CLÍNICOS EM ONCOLOGIA: PERFIL E ASPECTOS ENVOLVIDOS NAS SUAS DECISÕES

  2018cites this paper
• The Ethics of End-of-Trial Obligations in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania

  2018cites this paper
• Implementing post-trial access plans for HIV prevention research

  2018cites this paper
• Empirical investigation of ethical issues raised by two research ethics committees reviewing biomedical research in South Africa.

  2017cites this paper
• The ‘experimental public’ in longitudinal health research: views of local leaders and service providers in rural South Africa

  2017cites this paper
• Human dignity as a basis for providing post-trial access to healthcare for research participants: a South African perspective

  2017cites this paper
• Care in HIV drug trial closure: perspectives of research participants and staff in Uganda

  2017cites this paper
• South African National Health Act (No. 61 of 2003) vs. Emmanuel framework for ethical research (2004): implications for children research.

  2017influential citation
• Democratic reciprocity model: a justification of continued access to an investigational medicine in clinical research

  2017cites this paper
• Post-trial obligations in the Declaration of Helsinki 2013: classification, reconstruction and interpretation.

  2016cites this paper
• EBOLA and FDA: reviewing the response to the 2014 outbreak, to find lessons for the future

  2016cites this paper
• Should Research Ethics Encourage the Production of Cost-Effective Interventions?

  2016cites this paper
• Attitudes toward Post-Trial Access to Medical Interventions: A Review of Academic Literature, Legislation, and International Guidelines.

  2016cites this paper
• Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees

  2016cites this paper
• Chapter 6: Ethical considerations in health systems research

  2016cites this paper
• Marking Shifts in Human Research Ethics in the Development of Biobanking

  2015cites this paper
• Ethics in clinical trials

  2015cites this paper
• Ethical Review of Health Systems Research in Low- and Middle-Income Countries: A Conceptual Exploration

  2014cites this paper
• Exploring Academic and REB Members' Attitudes Toward Post-trial Access

  2014cites this paper
• Ethical issues in HIV prevention research with people who inject drugs

  2014cites this paper
• A new toolkit for conducting clinical trials in rare disorders.

  2014cites this paper
• A comparison of justice frameworks for international research

  2014cites this paper
• Reciprocity-Based Reasons for Benefiting Research Participants: Most Fail, the Most Plausible is Problematic

  2013cites this paper
• Ethical issues for control-arm patients after revelation of benefits of experimental therapy: a framework modeled in neuroblastoma.

  2013cites this paper
• Systematic Reviews of Reasons in Public Health Ethics Literature: A Roadmap

  2013cites this paper
• Pharmaceutical Companies vs. the State: Who is Responsible for Post-Trial Provision of Drugs in Brazil?

  2012cites this paper
• Closing the translation gap for justice requirements in international research

  2012cites this paper
• Post-trial access to study medication: a Brazilian e-survey with major stakeholders in clinical research

  2012cites this paper
• Forms of benefit sharing in global health research undertaken in resource poor settings: a qualitative study of stakeholders' views in Kenya

  2012cites this paper
• The Need for Systematic Reviews of Reasons

  2011cites this paper
• Ethical and Psychosocial Aspects of HIV/AIDS

  2011cites this paper
• Reasons Why Post-Trial Access to Trial Drugs Should, or Need not be Ensured to Research Participants: A Systematic Review

  2011influential citation
• Canadian Recommendations for Clinical Trials of Pharmacologic Interventions in Rheumatoid Arthritis: Inclusion Criteria and Study Design

  2011cites this paper
• Fornecimento de medicamentos pós-pesquisa

  2011cites this paper
• Application of a partnership model for transformative and sustainable international development.

  2010cites this paper
• Risk-benefit assessment in medical research—critical review and open questions

  2010cites this paper
• Acesso às drogas na pesquisa clínica

  2009cites this paper
• Access to Medications and Medical Care After Participation in HIV Clinical Trials: A Systematic Review of Trial Protocols and Informed Consent Documents

  2009cites this paper
• Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents.

  2009cites this paper
• Subjects’ views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study

  2009cites this paper
• Should post-trial provision of beneficial experimental interventions be mandatory in developing countries?

  2008cites this paper
• Introduction: Why Exploitation?

  2008cites this paper
• Ethical Principles in Clinical Research

  2007cites this paper
• Ethical Considerations in Neuroemergency Clinical Trials

  2006cites this paper
• Turning from damage caps to information disclosure: an alternative to tort reform.

  2005cites this paper